bromodeoxyuridine has been researched along with Tuberculosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackman, MA; Brincks, EL; Burkum, CE; Connor, LM; Cookenham, T; Freeman, ML; Kohlmeier, JE; Mohrs, M; Perona-Wright, G; Reiley, WW; Roberts, AD; Sell, S; Winslow, GM; Woodland, DL; Yager, EJ | 1 |
| Johnson, DW; Muscoplat, CC; Okino, FC; Schmidtke, JR | 1 |
| Lefford, MJ | 1 |
| Greinert, U; Müller-Quernheim, J; Schlaak, M; Schreiber, J; Zissel, G | 1 |
4 other study(ies) available for bromodeoxyuridine and Tuberculosis
| Article | Year |
|---|---|
Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infection.
Topics: Adoptive Transfer; Animals; Bromodeoxyuridine; CD8-Positive T-Lymphocytes; Female; Flow Cytometry; Immunologic Memory; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Orthomyxoviridae Infections; Receptors, CCR5; Receptors, CXCR3; Tuberculosis | 2011 |
5-Bromodeoxyuridine (BUdR) and light inactivation of proliferating Mycobacterium bovis and Mycobacterium avium sensitized bovine lymphocytes.
Topics: Animals; Bromodeoxyuridine; Cattle; Light; Lymphocytes; Mycobacterium avium; Mycobacterium bovis; Tuberculin; Tuberculosis; Tuberculosis, Bovine | 1980 |
Properties of peritoneal exudate lymphocytes that mediate tuberculin delayed-type hypersensitivity and anti-tuberculosis immunity. I. The effect of cytotoxic agents.
Topics: Animals; Ascitic Fluid; BCG Vaccine; Bromodeoxyuridine; Female; Hypersensitivity, Delayed; Immunity, Maternally-Acquired; Immunization, Passive; Lymphocytes; Mitomycins; Rats; Thymidine; Tuberculosis; Vinblastine | 1980 |
Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; Antitubercular Agents; Bromodeoxyuridine; Cells, Cultured; Chemical and Drug Induced Liver Injury; DNA Replication; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunity, Cellular; Isoniazid; Kidney Diseases; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nervous System Diseases; Rifampin; Tuberculosis | 1999 |